In 2019, the Danish pharmaceutical company Novo Nordisk reported that its diabetes care drugs had generated over 12.5 billion Danish kroner in Greater China. Founded in 1923, the firm specializes in producing diabetes medications. Novo Nordisk’s business in mainland China accounted for over ten percent of its total net sales in 2019.
…. more: Statista.com (Quelle/Source)